Holiday Hours

With the exception of Inova hospitals, Inova Emergency Care and Inova-GoHealth Urgent Care, all Inova outpatient offices will be closed for the Memorial Day holiday – Monday, May 27.

Pulmonary hypertension (PH) refers to elevated pressure in the vessels of the lungs. If affected, the arteries and veins in the lungs become narrow and stiff. As the result, the right side of the heart has to work harder to pump blood through the lungs. If left untreated, PH can lead to right heart failure.

The Pulmonary Hypertension Program at Inova Fairfax Hospital provides the highly specialized multi-disciplinary care required by patients dealing with various types of PH. Inova's lung experts are nationally-recognized for their expertise in diagnosing, treating and managing PH, utilizing the most effective treatments available. Our program has long been recognized for its research of different forms of pulmonary hypertension.

Patients receiving care from the Inova Pulmonary Hypertension Program have seamless access to numerous other medical and support programs. You can talk with the staff about any of the following options.

Dedication to holistic care of PH patients continues at our facility. Family members are encouraged to attend all appointments.

Specialty Services

Specialty consultant services are available, including:

  • Rheumatology
  • Congenital heart disease clinic (medical and surgical)
  • Interventional cardiology
  • Lung transplant
  • Nutrition
  • Pulmonary Rehabilitation

In-Hospital Supportive Services

  • Thoracic imaging
  • Nuclear medicine
  • Cardiac anesthesia
  • IAC-certified ECHO lab
  • Pulmonary diagnostics
  • Interventional radiology

Pulmonary Hypertension (PH) Support Groups

Websites to Search for More Information

Our Team

As advocates in the pulmonary hypertension medical community, our team, led by Director Oksana Shlobin, MD, participates in fundraising, outreach and education and serves in leadership positions with organizations worldwide working to improve the lives of patients living with PH, including:

American College of Chest Physicians (ACCP)

  • Vice-Chair, Cardiovascular and Pulmonary Vascular Disease Network, Dr. Shlobin
  • Oversight Committee and Venous Thromboembolism Treatment Guidelines Committee, Dr. King

Pulmonary Hypertension Association (PHA)

Pulmonary Fibrosis Foundation (PFF)

Pulmonary Vascular Research Institute (PVRI)

  • Chair, International Drug Development Institute (IDDI), Group 3 PH Committee, Dr. Nathan
  • International Drug Development Institute (IDDI), Group 3 PH Committee, Dr. Shlobin
  • Lung Transplantation Committee, Dr. Khangoora

World Symposium on Pulmonary Hypertension (WSPH) Association

  • 2024 Chair of the Taskforce of Pulmonary Hypertension in Chronic Lung Diseases, Dr. Shlobin
  • 2018 Chair of the Taskforce of Pulmonary Hypertension in Chronic Lung Diseases, Dr. Nathan

See All Team Members

ph program team
Pulmonary Hypertension Program Team